Edgewood Management’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Sell
80,000
-20,000
-20% -$183K 0.01% 74
2026
Q1
$1.02M Hold
100,000
0.01% 66
2025
Q4
$628K Hold
100,000
﹤0.01% 75
2025
Q3
$298K Hold
100,000
﹤0.01% 82
2025
Q2
$190K Hold
100,000
﹤0.01% 79
2025
Q1
$146K Hold
100,000
﹤0.01% 80
2024
Q4
$185K Hold
100,000
﹤0.01% 80
2024
Q3
$237K Hold
100,000
﹤0.01% 72
2024
Q2
$275K Hold
100,000
﹤0.01% 71
2024
Q1
$418K Hold
100,000
﹤0.01% 68
2023
Q4
$324K Hold
100,000
﹤0.01% 68
2023
Q3
$300K Hold
100,000
﹤0.01% 70
2023
Q2
$114K Hold
100,000
﹤0.01% 80
2023
Q1
$167K Hold
100,000
﹤0.01% 80
2022
Q4
$124K Hold
100,000
﹤0.01% 81
2022
Q3
$422K Hold
100,000
﹤0.01% 69
2022
Q2
$389K Hold
100,000
﹤0.01% 68
2022
Q1
$489K Hold
100,000
﹤0.01% 70
2021
Q4
$548K Buy
100,000
+50,000
+100% +$209K ﹤0.01% 70
2021
Q3
$181K Hold
50,000
﹤0.01% 80
2021
Q2
$198K Hold
50,000
﹤0.01% 79
2021
Q1
$239K Buy
50,000
+10,000
+25% +$49.2K ﹤0.01% 78
2020
Q4
$119K Hold
40,000
﹤0.01% 79
2020
Q3
$128K Hold
40,000
﹤0.01% 77
2020
Q2
$157K Hold
40,000
﹤0.01% 74
2020
Q1
$124K Buy
40,000
+20,000
+100% +$68.9K ﹤0.01% 76
2019
Q4
$65K Buy
+20,000
New +$80.5K ﹤0.01% 84

Other funds holding ARMP

Edgewood Management's ARMP Position: Q2 2026 in Review

Edgewood Management reduced its Armata Pharmaceuticals (ARMP) stake by 20% in Q2 2026, selling an estimated $183K and leaving 80,000 shares worth $518K. The position accounts for 0.01% of the portfolio, ranked #74.

Edgewood Management first reported a position in ARMP in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.02M in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Edgewood Management held 80,000 shares of Armata Pharmaceuticals worth $518K as of Q2 2026.
  • Edgewood Management sold 20,000 Armata Pharmaceuticals shares in Q2 2026, an estimated $183K.
  • Armata Pharmaceuticals made up 0.01% of Edgewood Management's portfolio in Q2 2026, its #74 holding.
  • Edgewood Management first reported a position in Armata Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Edgewood Management's Armata Pharmaceuticals position peaked at $1.02M in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.